United States Biotechnology & Medical Research

Senti Biosciences, Inc. (SNTI)

Track

Track

Senti Biosciences, Inc. experienced multiple insider sales during early February 2025. CEO Timothy K. Lu and President Kanya Rajangam executed disposals of company equity. Additionally, a former affiliate filed a proposed sale notice in December 2024. These activities represent the most recent recorded movements within the firm's internal ownership structure.
Ticker: SNTI Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.5
Lu Timothy K CEO Executive Director
Transaction date
Sale
Price
498.60
Quantity 92,141 -31.0%
Value US$2,866,541
3.5
Rajangam Kanya Pres. & Chief Med. & Dev. Off. Officer
Transaction date
Sale
Price
19.04
Quantity 47,610 -24.1%
Value US$4,141,175
3.5
Lu Timothy K CEO Executive Director
Transaction date
Sale
Price
431.29
Quantity 96,176 -4.7%
Value US$623,735
3.5
Rajangam Kanya Pres. & Chief Med. & Dev. Off. Officer
Transaction date
Sale
Price
4.07
Quantity 1,297 -12.8%
Value US$5,279
2.7
Omid C Farokhzad Former Affiliate
Transaction date
Proposed sale
Price
2.16
Quantity 83,277
Value US$179,878
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-06 2025-02-06 S Sale
3.5
Lu Timothy K

CEO

Executive Director
92,141 -31.0%
498.60
US$2,866,541 		92,141 -31.0% 498.60 US$2,866,541
2025-02-06 2025-02-06 S Sale
3.5
Rajangam Kanya

Pres. & Chief Med. & Dev. Off.

Officer
47,610 -24.1%
19.04
US$4,141,175 		47,610 -24.1% 19.04 US$4,141,175
2025-02-06 2025-02-04 S Sale
3.5
Lu Timothy K

CEO

Executive Director
96,176 -4.7%
431.29
US$623,735 		96,176 -4.7% 431.29 US$623,735
2025-02-06 2025-02-04 S Sale
3.5
Rajangam Kanya

Pres. & Chief Med. & Dev. Off.

Officer
1,297 -12.8%
4.07
US$5,279 		1,297 -12.8% 4.07 US$5,279
2024-12-02 2024-12-02 PrS Proposed sale
2.7
Omid C Farokhzad

Former Affiliate
83,277
2.16
US$179,878 		83,277 2.16 US$179,878
Explore more

More insider trading research around Senti Biosciences, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America